scispace - formally typeset
S

Seyed Hossein Hosseini

Researcher at Tehran University of Medical Sciences

Publications -  5
Citations -  628

Seyed Hossein Hosseini is an academic researcher from Tehran University of Medical Sciences. The author has contributed to research in topics: Randomized controlled trial & Intensive care unit. The author has an hindex of 4, co-authored 5 publications receiving 203 citations.

Papers
More filters
Journal ArticleDOI

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.

Inspiration Investigators, +63 more
- 27 Apr 2021 - 
TL;DR: In this paper, the authors evaluated the effects of intermediate-dose vs standard-dose prophylactic anticoagulation among patients with COVID-19 admitted to the intensive care unit (ICU).
Journal ArticleDOI

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.

Behnood Bikdeli, +64 more
TL;DR: In this article, the authors report the final (90-day) results of the Intermediate versus Standard-dose Prophylactic anticoagulation In cRitically-ill pATIents with COVID-19: An opeN label randomized controlled trial (INSPIRATION) study.
Posted ContentDOI

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

TL;DR: In this paper, the authors provide a perspective of the ongoing or completed randomized controlled trials related to antithrombotic strategies used in coronavirus disease-2019, the opportunities and challenges for the clinical trial enterprise, and areas of existing knowledge, as well as data gaps that may motivate the design of future RCTs.
Journal ArticleDOI

Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial.

TL;DR: PDxane® was of similar efficacy and safety compared to Clexane® in preventing VTE following major obstetric-gynecological surgeries and could be a safe and effective alternate for VTE prophylaxis in the patients undergoing such types of surgeries.